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Neural progenitor cells (NPCs) of feline origin (cNPCs) have demonstrated utility in transplantation experiments, yet are diﬃcult
togrowinculturebeyondthe1monthtimeframe.Hereweuseanenriched,serum-freebasemedium(Ultraculture)andreportthe
successful long-term propagation of these cells. Primary cultures were derived from fetal brain tissue and passaged in DMEM/F12-
basedorUltraculture-basedproliferationmedia,bothinthepresenceofEGF+bFGF.CellsinstandardDMEM/F12-basedmedium
ceased to proliferate by 1-month, whereas the cells in the Ultraculture-based medium continued to grow for at least 5 months (end
ofstudy)withnoevidenceofsenescence.TheUltraculture-basedculturesexpressedlowerlevelsofprogenitorandlineage-associat-
ed markers under proliferation conditions but retained multipotency as evidenced by the ability to diﬀerentiate into neurons and
glia following growth factor removal in the presence of FBS. Importantly, later passage cNPCs did not develop chromosomal aber-
rations.
1.Introduction
Themammaliancentralnervoussystem(CNS)hasarestrict-
ed capacity for self-repair and regeneration and, as a con-
sequence, the extent of clinical recovery from CNS injury or
disease is generally limited. Because of this unmet clinical
need, much work has been devoted to exploring potential
ways of enhancing clinical outcomes in the setting of debil-
itating neurological conditions. One particularly interesting
approach is the transplantation of allogeneic neural progeni-
torcells(NPCs).Thesemultipotentcellsarederivedfromthe
developing nervous system and, under deﬁned serum-free
conditions, are capable of at least limited expansion in cul-
ture, followed by diﬀerentiation into mature neurons and
glia, either following cessation of mitogenic stimulation in
vitro or transplantation to the diseased CNS [1, 2].
There are a number of characteristics of NPCs that re-
commend them for application to neural repair strategies.
From a practical standpoint, the proliferative capability of
the cells mentioned above allows for the generation of cell
banks [3], thereby decreasing the need for continued deriva-
tion from donor tissue. From a biological standpoint, the
ability of NPCs to exhibit directed migration to areas of dis-
ease and integrate into the local cytoarchitecture represents a
major breakthrough compared to previous work, for exam-
ple, with fetal tissue transplantation [4, 5]. From a clinical
standpoint, the immune tolerance-aﬀorded allogeneic NPCs
in animal studies [6–8] would appear to obviate the need
formandatoryimmunesuppressioninmanycases,hopefully
including allografts in humans. If this is the case, it would
substantially decrease the therapeutic risk to patients. In
addition, it would appear that progenitor cells of this type
convey a substantially decreased risk of tumor formation,
particularly when compared to analogous cells derived from
pluripotent cell types [9].
In addition to their potential role in cell replacement,
NPCs also represent an attractive method for gene delivery,
particularly with respect to neuroprotective cytokines. These
moleculesaregeneproductsthatarerapidlydegradedinvivo
by endogenous proteases and notably include trophic factors2 Stem Cells International
such as glial cell line-derived neurotrophic factor (GDNF). It
has been demonstrated that NPCs can be genetically modi-
ﬁed to express these types of factors ex vivo, expanded in
number, and subsequently transplanted for study [10, 11].
Giventhatthesecellsaretypicallywelltoleratedimmunolog-
ically, genetically modiﬁed NPCs could provide a method of
sustained drug delivery to local sites within the brain, retina,
and spinal cord. This option is of interest in species, where
NPCs can be successfully isolated, and where models of CNS
disease are available.
Progenitor or precursor cells have now been isolated and
grown from viable brain tissue in a broad range of mam-
malian species, including mouse, rat, cat, pig, sheep, dog,
monkey, and human [12]. The cat represents a model of
interest for neural repair strategies because of the potential
for detailed electrophysiological and behavioral studies. In
previous work, we and another group have reported the iso-
lation of feline neural progenitor-like cells, combined with
successful transplantation to the dystrophic retina [13]a n d
the normal brain [14] of allorecipients. Nevertheless, it has
proven diﬃcult to grow these cells for extended periods in
culture using conventional protocols. This lack of in vitro
expansion hampers further research by restricting the num-
ber of studies that can be performed from a given isolation.
Here, we identify a modiﬁed culture method that allows for
sustained, abundant growth of feline neural progenitor cells
suﬃcient for banking. We provide additional characteriza-
tion of these cells, including examination of karyotype and
analysisof gene expression at multiple time points in culture.
2. MaterialsandMethods
2.1. Isolation and Culture of NPCs from the Cat (cNPCs). The
isolation of cNPCs followed a protocol similar to that des-
cribed previously [13], but in this case the donor was a 47-
day timed-pregnant domestic cat (E47). Fetuses were remov-
ed under terminal anesthesia at an academic veterinary faci-
lity and shipped on ice to the site of cell isolation and cul-
ture. Upon arrival, brains were removed by dissection and
the forebrain separated from the cerebellum and brainstem.
Forebrain tissue was relocated to a petridish containing cold
DMEM (Invitrogen, Carlsbad, CA, USA). The tissue was
minced using 2 scalpels and then enzymatically digested us-
ing 0.05% TrypLE Express (Invitrogen). The resulting cell
suspension was washed repeatedly and dissociated by repeat-
ed,gentleaspirationusingaﬂame-polishedglasspipette.The
resulting cells were then divided and seeded into 1 of 2
diﬀerent complete culture media, namely, standard medium
(SM) or Ultraculture-based medium (UM). SM consisted of
Advanced DMEM/F12 (Invitrogen), 1% by volume N2
neural supplement (Invitrogen), 1% GlutaMax (Invitrogen),
50U/mL penicillin-streptomycin (Invitrogen), 20ng/mL
epidermal growth factor (recombinant human EGF, Invit-
rogen) and 20ng/mL basic ﬁbroblast growth factor (recom-
binant human bFGF; Invitrogen). To promote adherence,
5% FBS (Sigma) was also included at the time of initial
plating. The following day all medium in cultures was com-
pletely replaced with serum-free SM. The remaining half of
the primary cells were seeded in an alternate proliferation
medium, henceforth designated UltraCulture-based med-
ium (UM), containing Ultraculture (Lonza), 1% Gluta-
Max, 50U/mL penicillin-streptomycin, 20ng/mL epidermal
growth factor, and 20ng/mL basic ﬁbroblast growth factor.
The plating density was 0.5 × 106 cells/mL for both condi-
tions.Subsequently,cellswerefedbymediumexchangeevery
2 to 3 days and passaged at conﬂuence using TrypLE Ex-
press and gentle trituration through a ﬂame-polished glass
pipette. At each passage, cell number was counted using a
hemocytometer.
2.2. Cytogenetic Analysis (Chromosome Counting and Kary-
otyping). Conﬂuent cNPCs generated in UM were harvested
at culture passages 8 and 14 and prepared for analysis, as
follows. Cells were plated onto a T-25 ﬂask, and the media
were changed 24 hours before harvesting the culture to
stimulate cell division and maximize the mitotic index. The
cellswerethenmitoticallyarrestedwithcolcemid(KaryoMax
Colcemid solution, Invitrogen) at a ﬁnal working concen-
trationof0.12μg/mL at37◦C for20 minutes. Isolated cNPCs
were harvested for hypotonic treatment in 0.075M KCl solu-
tion at room temperature for 25 minutes. The cells were pel-
leted by centrifugation at 1000rpm for 8 minutes and ﬁxed
in ice-cold ﬁxative (3:1 methanol: glacial acetic acid) for
10min. After a second wash in ﬁxative, the cells were resus-
pended in 2mL ﬁxative. Slides were prepared by dropping
the cell suspension onto dry microscope slides prewashed
with ﬁxative. G-banded karyotyping was performed by Cell
Line Genetics LLC (Madison, WI, USA).
2.3. RNA Isolation and cDNA Synthesis. Total RNA was ex-
tracted from passage 8 cNPCs using the RNeasy Mini Kit
(Qiagen,Valencia,CA,USA)accordingtothemanufacturer’s
protocol. DNase I was used to digest and eliminate any con-
taminatinggenomicDNA.TwomicrogramsoftotalRNAina
20μL reaction were reverse-transcribed using an Omniscript
cDNA Synthesis Kit (Qiagen, Valencia, CA, USA).
2.4. Quantitative PCR (qPCR). qPCR was performed on an
Applied Biosystems 7500 Fast Real-Time PCR Detection Sys-
tem (Applied Biosystems, Foster, CA, USA) following pro-
tocols previously described [15]. Brieﬂy, 20μLt o t a lr e a c t i o n
wasmadeupof10μL2xPowerSYBRGreenPCRMasterMix
(Applied Biosystems, Foster, CA, USA), 100ng cDNA, and
gene speciﬁc primers (Table 1) at a concentration of 300μM.
Sampleswereinitiallydenaturedat95◦Cfor10min,followed
by 40 cycles of PCR ampliﬁcation (15 seconds at 95◦Ca n d
1m i n u t ea t6 0 ◦C). To normalize template input, β-actin
(endogenous control) transcript level was measured for each
sample. Melting curves were determined to conﬁrm ampliﬁ-
cation of the expected fragment. Fold change and heat map
were generated using JMP 4.1 and DataAssist 2.0 software.
2.5. Induction of cNPC Diﬀerentiation. The cNPCs were cul-
tured in UM or UM-FBS that contained 10%FBS but no
added growth factors with the same cell density, 0.3 ×
106 cells/mL. Culture media was exchanged every 2 days.Stem Cells International 3
Table 1: Cat-speciﬁc primers for real-time PCR.
Genes Description Forward (5 –3 )R e v e r s e ( 5  –3 )
Annealing
temperature
(◦C)
Product size
(base pairs)
Nestin Intermediate
ﬁlament, Progenitor CTGGAGCAGGAGAAGGAGAG GAAGCTGAGGGAAGCCTTG 60 180
Sox-2 Transcription factor,
progenitor ACCAGCTCGCAGACCTACAT TGGAGTGGGAGGAAGAGGTA 60 154
Vimentin Intermediate
ﬁlament, progenitor ATCCAGGAGCTACAGGCTCA GGACCTGTCTCCGGTACTCA 60 247
Pax 6 Transcription factor,
progenitor AGGAGGGGGAGAGAATACCA CTTTCTCGGGCAAACACATC 60 183
Notch1 Surface receptor,
progenitor CAGTGTCTGCAGGGCTACAC CTCGCACAGAAACTCGTTGA 60 231
CD133 Progenitor AGGAAGTGCTTTGCGGTCT TGCCAGTTTCCGAGTCTTTT 60 120
Cyclin D2 Cell cycle protein CAAGATCACCAACACGGATG ATATCCCGCACGTCTGTAGG 60 162
Ki-67 Cell cycle protein,
proliferation TCGTCTGAAGCCGGAGTTAT TCTTCTTTTCCCGATGGTTG 60 150
CD81 Tetraspaniin CCACAGACCACCAACCTTCT CAGGCACTGGGACTCCTG 60 156
EGFR EGF receptor,
surface marker AACTGTGAGGTGGTCCTTGG CGCAGTCCGGTTTTATTTGT 60 231
FABP7 fatty acid binding
protein TGGAGGCTTTCTGTGCTACC TGCTTTGTGTCCTGATCACC 60 165
β3-tubulin Microtubule protein,
neural precursor CATTCTCGTGGACCTTGAGC GCAGTCGCAATTCTCACATT 60 199
Map2
Microtubule-
associated,
neuron
ACCTAAGCCATGTGACATCCA CTCCAGGTACATGGTGAGCA 60 152
GFAP Intermediate
ﬁlament, glia CGGTTTTTGAGGAAGATCCA TTGGACCGATACCACTCCTC 60 188
AQP4 water channel
protein TACACTGGTGCCAGCATGA CACCAGCGAGGACAGCTC 60 118
SDF 1 stromal-cell-derived
factor-1 ACAGATGTCCTTGCCGATTC CCACTTCAATTTCGGGTCAA 60 152
CXCR4 fusin TCTGTGGCAGACCTCCTCTT TTTCAGCCAACAGCTTCCTT 60 220
Dcx Doublecortin,
neuroblast marker GGCTGACCTGACTCGATCTC GCTTTCATATTGGCGGATGT 60 222
Lhx2 Homeobox
transcription factor GATCTGGCGGCCTACAAC AGGACCCGTTTGGTGAGG 60 224
NCAM
(CD56)
Adhesion molecule,
surface marker AGAACAAGGCTGGAGAGCAG TTTCGGGTAGAAGTCCTCCA 60 172
NogoA Reticulon 4, surface
protein TTTGCAGTGTTGATGTGGGTA TAACAGGAACGCTGAAGAGTGA 60 100
nucleostemin Nucleolar protein CAGTGGTGTTCAGAGCCTCA CCGAATGGCTTTGCTGTAA 60 165
Pbx 1 Transcription factor CTCCGATTACAGAGCCAAGC GCTGACCATACGCTCGATCT 60 166
β-actin Housekeeping gene GCCGTCTTCCCTTCCATC CTTCTCCATGTCGTCCCAGT 60 168
The morphology of cells was monitored every day, and the
cells were photographed on days 1, 3, 5, and 7.
2.6.Immunocytochemistry. After4monthsinculture,cNPCs
wereplatedonfour-wellchamberslidesineitherUMorUM-
FBS medium and fed every two days. On day 5, cells were
ﬁxed with freshly prepared 4% paraformaldehyde (Invitro-
gen) in 0.1M phosphate-buﬀered saline (PBS) for 20 min-
utes at room temperature. Fixed cells were washed with PBS,
then they were incubated for 1 hour at room temperature in
antibody blocking buﬀer containing the following: PBS con-
taining 10% (v/v) normal donkey serum (Sigma), 0.3% Tri-
ton X-100, and 0.1% NaN3 (Sigma-Aldrich, Saint Louis,
MO, USA). Slides were then incubated in primary antibodies
(Table 2)a t4 ◦C overnight. After washing, slides were incu-
bated for 1 hour at room temperature in ﬂuorescent-conju-
gated secondary antibody, 1:400 Alexa Fluor546 goat anti-
mouse, followed by washings. Cell nuclei were counterstain-
ed with 1.5μg/mL 4 ,6-diamidino-2-phenylindole (DAPI;4 Stem Cells International
Table 2: Primary antibodies for immunocytochemistry.
Antigen Host species and reactivity in retina Dilution Source
Nestin Mouse monoclonal; progenitors, reactive glia 1:200 BD, 611658
Vimentin Mouse monoclonal; progenitors, reactive glia 1:200 Sigma, V6630
βIII-tubulin Mouse monoclonal; immature neurons 1:200 Chemicon, MAB1637
Ki-67 Mouse monoclonal; proliferating cells 1:200 BD, 556003
GFAP Mouse monoclonal; Astrocyte, reactive glia 1:200 Chemicon, MAB3402
Day 0 1 week 2 weeks 4 weeks 4 months
SM
UM
Figure 1: Morphology of cNPCs in diﬀerent proliferation media at serial time points. Upper panel shows cNPCs cultured in SM and the
lower panel cells of the same age in UM. Cultures are shown on day 0, after 1, 2, and 4 weeks as well as 4 months (UM only). In both media
the cells exhibited morphologic features consistent with primitive neural cells throughout the period examined. In both cases, the adherent
cells extended processes and expanded greatly during the initial week. The cells in SM ceased expanding during the ﬁrst month and were not
evaluated beyond the 3-month time point, whereas those in UM continued to expand throughout the course of the study. Scale bar: 100μm.
Invitrogen, Molecular Probes, Eugene, OR, USA) in Vec-
tashield Hard Set Mounting Medium (Vector Laboratories,
Burlingame, CA, USA) for 15min at room temperature.
Negative controls for immunolabeling were performed in
parallel using the same protocol but with omission of the
primaryantibody.Fluorescentlabelingwasjudgedaspositive
only with reference to the negative controls. Immunoreactive
cellswerevisualizedandimagesrecordedusingaNikonﬂuo-
rescent microscope (Eclipse E600; Nikon, Melville, NY,
USA).
3. Results
3.1. Comparison of cNPCs Grown in Diﬀerent Proliferation
Media. Proliferative cultures were obtained from forebrain-
derived feline NPCs seeded and maintained in both types of
media(SMandUM);however,onlythoseseededinUMcon-
tinued to expand throughout the duration of the study (5
months). The cells in both types of media exhibited mor-
phologic features consistent with primitive neuroectodermal
cells throughout their growth period (Figure 1). In both cul-
tures, the majority of cells were adherent to the surface of the
ﬂask and continued to proliferate, forming a pattern of ran-
dom networks and nodal clusters as is typical of mammalian
neural progenitors when not grown as suspended neuro-
spheres.
The morphology of cNPCs cultured in the two diﬀerent
growthmediawasalsoexamined.Inbothconditions,theini-
tially dissociated cells divided and formed small clusters over
the ﬁrst week in culture. During this period, cellular pro-
cesses had started to form by day 3 and were greatly elaborat-
ed by the end of the ﬁrst week. Cells cultured in SM showed
little evidence of proliferation beyond week 3, but continued
to survive up to 3 months. In contrast, cells cultured in UM
established stably expanding populations. The cNPCs con-
tinued to expand vigorously, while maintaining progenitor
morphology, although a tendency of the cells to enlarge and
ﬂatten was observed (Figure 1).
3.2. Long-Term Expansion of cNPC Cells Is Possible in UM.
The growth characteristics of cNPCs are plotted in Figure 2.
Initial growth of cells was observed in either medium, but
sustained expansion was only achieved using UM. The
numberofcellsinSMmediumincreasedinitiallyandpeaked
shortly after day 20. After that, the total cell count began to
drop, and no further passaging or counting was performed
although the cells continued to survive up to at least 3
months. In contrast, the cNPCs in UM continued to increase
steadily, without indications of senescence, throughout the
5-month duration of this study.
3.3. Cytogenetics of cNPCs during Extended Culture. Because
increased rates of cellular proliferation can be the result of
chromosomal abnormalities arising during extended periods
of cell culture, the karyotypic stability of cNPCs cultures in
UM was evaluated by chromosome counting and G-banded
karyotyping. Cytogenetic analysis was performed on twentyStem Cells International 5
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Figure 2: Expansion capacity of cNPC cells in long-term culture. Cells were cultured in 1 of 2 proliferation media of diﬀering composition
and counted at each passage using a hemocytometer. The number of cells in SM medium (red) increased initially, then began to drop shortly
after day 20, with no measurable proliferation beyond 1 month. In contrast, cultures grown in UM (blue) exhibited sustained growth
throughout the course of the study (143 days), with no evidence of senescence. The rate of expansion did not diminish with passage number.
Numbers on x-axis represent days in culture at each passage, the y-axis shows cell number as total estimated yield.
G-banded metaphase cells from passage 8 (day 50) and from
passage14(day87)timepointsthatroughlycorrespondedto
possible upward inﬂections in the growth curve. The results
showed that the cells from both time points possessed nor-
mal feline 38XX karyotypes (Figure 3), indicating that the
increased proliferation rate seen was not the result of a cul-
ture-induced chromosomal abnormality.
3.4. Quantitative Evaluation of the Eﬀect of Diﬀerent Culture
Media on cNPC Gene Expression. Having determined that
UM eﬀectively sustains the proliferation of NPCs of feline
origin, whereas the conventional media formation did not, it
was of interest to compare the phenotype of the cells grown
using these methods. In order to look for diﬀerences related
to the alternate proliferation conditions used, we compared
gene expression proﬁles for cNPCs grown in SM versus
UM at the 1 month time point using quantitative RT-PCR
(Figures 4(a) and 4(b)).
Both sampled populations expressed the neural progeni-
tor-associated genes nestin, sox-2, vimentin, and notch1
as well as the proliferation markers cyclinD2 and Ki-67
(Figure 4(a)). Expression of the markers CD81 and FABP7,
which are also known to be expressed by NPCs [16–18],
was detected as well. Low expression of the early neuronal
marker β-III tubulin was seen, as reported previously [13].
The mature neuronal and astroglial markers Map2 and
GFAP were detectable, the latter more prominently than the
former. Overall, these results were consistent with the main-
tenance of markers associated with neural progenitor popu-
lations by cNPCs when grown in UM, including the modest
but detectable tendency for ongoing, spontaneous diﬀeren-
tiation along the neuronal lineage, as previously reported in
analogous cells from various mammalian species.
Looked at more closely, there were similarities and dif-
ferences in the level of expression for particular markers
(Figure 4(b)). Less than 2 fold variance between conditions
was observed for expression of the majority of markers
including AQP4, β3-tubulin, CD9, CD81, CyclinD2, EGFR,
GFAP, Lhx2, NCAM, nestin, nogoA, notch1, Pax6, Sox2, and
vimentin. Growth in UM was associated with greater than 2
fold increased expression in the neuroblast marker DCX, the
neuronal marker Map2, the transcription factor Pbx1, and
the migration-associated marker SDF1. Markers that were
greater than 2 fold lower in UM were CXCR4, FABP7 and
Ki-67. Of note, the most upregulated marker (SDF1) is a
receptor for the migration factor CXCR4, which was down-
regulated.
3.5. Sequential Analysis of cNPC Gene Proﬁle with Time in
Culture. To examine the phenotypic stability of cRPCs dur-
ing extended culture in UM, we employed qPCR, in this case
to compare the expression proﬁle obtained at 2 weeks to that
p r e s e n ta t1 ,2 ,3 ,a n d5m o n t h s( Figure 5). A preponderance
of the markers examined showed a tendency to decrease
with time in culture. This trend included progenitor-
associated and neurodevelopmental markers as well as some
markers associated with further lineage restriction. Both
heat map and cluster analysis indicated an overall drop in
marker expression between the 1- and 2-month time points
(Figure 5(a)). Interestingly, this is the same time frame in6 Stem Cells International
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Figure 4: Comparison by qPCR of gene expression proﬁle for cNPCs in diﬀerent culture media. The cNPCs were cultured in either SM or
UM for 1 month prior to testing. (a) heat map display showing relative expression levels of 23 genes expressed by NPCs or related progeny
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expression appears increasingly green, and higher expression increasingly red. Viewed in this way, the general similarity of the 2 conditions is
evident in that the color of a particular gene tends to be conserved across conditions, even if the intensity often varies. (b) fold change, with
SM used as calibrator. Note that expression is represented on a log2 scale, such that 1.00 corresponds to a 2 fold change. Viewed in this way,
diﬀerences in expression are highlighted. The majority of genes showed less than 2 fold change (between 1.00 to −1.00, on log2 scale), again
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Figure 5: Comparison of gene expression from cNPCs at diﬀerent time points in UM via qPCR. A 22-gene proﬁle was assayed at each time
point. The initial time point for comparison was 2 weeks (calibrator), followed by 1, 2, 3 and 5 months. (a) viewed as a heat map, there was
an apparent overall drop in marker expression (shift from red towards green end of spectrum), and this was most evident between the 1- and
2-month time points, both visually and by cluster analysis (dendrogram at top). (b) data viewed as RQ (fold change) conﬁrms the prevalent
downward trend with time as well as highlighting the quantitative diﬀerences in fold change between markers. Error bars show standard
deviation.
which the cells in UM diverged in growth characteristics
from those in SM, as seen above in Figure 2. Viewed as a his-
togram,theqPCRdatashowedasequentialdownwardtrend,
although expression levels appeared to be leveling oﬀ at the
latter time points (Figure 5(b)). Again, this is concomitant
to the robust proliferation seen beyond 1 month in the UM
condition.
3.6. Diﬀerentiation. Having determined that cNPCs can be
grown beyond the 1-month time point using UM, it was im-
portant to conﬁrm whether cNPCS grown in this medium
retain the potential to diﬀerentiate into both neuronal and
glial cell types. As a ﬁrst step, cNPCs (4 months, P26) were
dissociated into single cells and induced to diﬀerentiate by
culture in UM without growth factors, but containing 10%
serum (UM-FBS), for 7 days. The cells cultured in UM-FBS
appeared similar but exhibited a more ﬂattened morphology
than undiﬀerentiated controls (Figure 6). Interestingly, the
cultures in UM-FBS reached conﬂuence more rapidly than
those in UM. The next step was to examine the expression of
relevant markers.
3.7. Eﬀect of UM-FBS on Marker Expression of cNPCs, Evalu-
ated by Immunocytochemistry. Immunocytochemical analy-
sis (Figure 7) at the same time point (4 months, P26) con-
ﬁrmed that feline cells cultured in UM expressed a numbers
of markers associated with neural precursor cells. These in-
cludedstrongexpressionoftheintermediateﬁlamentsnestin
andvimentinaswellastheproliferationmarkerKi-67.There
wasalsotracelabelingforthelineagemarkersβ3-tubulinand
GFAP,bothofwhicharecytoskeletalproteins.β3-tubulinisa
marker of neurons, and GFAP is strongly expressed by astro-
cytes. These data are suggestive of a small but detectable level
of spontaneous diﬀerentiation in the cultures under pro-
liferation conditions, as is expected with cells of this type.
At 5 days after induction of diﬀerentiation in UM-FBS,
very few cells remained nestin positive, the signal for vimen-
tin persisted at a diminished level, and expression of Ki-67
had decreased notably. In contrast, many more cells were
positiveforβ3-tubulinandasubsetofcellsGFAPwasstrong-
ly positive for GFAP, consistent with diﬀerentiation along
neuronal as well as glial lineages (Table 3).
4. Discussion
Since their initial isolation, neural progenitor cells have been
viewed as a powerful research tool for experimental investi-
gation of novel approaches to cell replacement throughout
the central nervous system (CNS). The recognized potential
of NPC transplantation-based regenerative therapy for CNS
diseaseshasgeneratedconsiderableenthusiasmamongmany
investigators and resulted in rapid growth of the ﬁeld. The
scientiﬁc understanding of NPCs has increased accordingly,
although transplantation of these cells has yet to achieve
accepted clinical use. One challenge has been growing suf-
ﬁcient quantities of the cells, and this is, therefore, a fun-
damental area deserving of additional attention. Reﬁnement
and the optimization of culture conditions is an obvious ini-
tial approach to further sustaining the proliferation of NPCs
in vitro. It is also important to consider that the culture8 Stem Cells International
Table 3: Estimated percentage and intensity of labeling of cultured cNPCs for speciﬁc markers after 5-day exposure to diﬀerentiation condi-
tions (UM-FBS). +: weak expression; ++: moderate expression; +++: strong expression.
Nestin Vimentin β3-tubulin Ki-67 GFAP
UM 100/++ 100/+++ 60/+ 85/++ 5/+
UM-FBS 2/+ 100/++ 85/++ 60/+ 35/+++
Day 1 Day 3 Day 5 Day 7
U
M
U
M
-
F
B
S
Figure 6: Morphology of cNPCs grown under proliferation versus diﬀerentiation conditions. Cultured cNPCs grown under proliferation
conditions (UM), beginning at P26 (4 months), maintained the appearance of neural progenitors, while those grown under diﬀerentiation
conditions (UM-FBS) appeared similar but exhibited a more ﬂattened morphology. Dotted vertical lines represent passaging/reseeding,
thereby accounting for the decreased cell density in images to the right of those points. Cells in the UM-FBS condition reached conﬂuence
more quickly.
requirements of progenitor cells may diﬀer between species.
Research has shown that extended culture of neural progeni-
torsisoftenassociatedwithlossofmultipotency,particularly
a reduced potential to generate neurons, together with loss
of self-renewal, as reﬂected in a marked propensity towards
early senescence [19, 20]. A pertinent issue is the extent to
which changes in culture conditions might enhance the ex-
pansion of functionally multipotent NPCs.
Feline NPCs can be diﬃcult to propagate using conven-
tional serum-free conditions. Here, we directly compared
two variations on serum-free proliferation media, SM and
UM, which diﬀered in base medium but contained the same
growth factors. Both formulations were used to examine
their ability to sustain the proliferation and development of
cNPCs derived from E47 brain tissue. In the more conven-
tional SM medium, cNPCs stopped dividing and began to
senesce by 1-month in culture. In UM, the cells continued to
exhibit vigorous growth for up to 5 months, the latest time
point examined, thereby allowing the banking of consider-
able numbers of mitotically active cNPCs. Although cNPCs
grown in SM and UM appear similar in terms of certain
key genes expressed, quantitative analysis of expression level
did reveal diﬀerences between the conditions at the 1 month
point. Interestingly, the expression level of the majority of
genes, including progenitor and lineage markers, was down-
regulated in UM versus SM. Furthermore, this tendency
toward downregulation in UM was even more pronounced
beyond the 1-month time point, although the possible trend
toward a new, lower set point in expression was noted. The
reason for this is not clear, but might relate to a state of con-
tinuous, rapid cell division. What is clear is that UM is
strongly permissive of feline NPCs survival and proliferation
in vitro, whereas use of conventional SM medium rapidly
leads to a failure to propagate.
One possible explanation for the facile growth exhibited
by cNPCs in UM could be spontaneous immortalization.
The cells in UM displayed repeated upward inﬂections in
growth rate with time in culture that might reﬂect dysregula-
tion of the cell cycle. It is known that immortalization of
NPCs can occur with extended time in culture, and that such
events are frequently associated with abnormalities in kary-
otype. To examine this, we evaluated whether karyotypic
alterations were present in our cells, and the results showed
that despite 14 passages in UM, the karyotype remained sta-
ble. Therefore, the improved growth seen in UM cannot be
attributed to changes in karyotype.
Because altered gene expression might be associated with
a loss of multipotency, it was important to conﬁrm whether
NPCs grown in UM maintain their ability to diﬀerentiate
into cells of neural lineage. Comparing various progenitor
markers and diﬀerentiation markers in UM versus UM-FBS
conditions, we found that expression levels of progenitor
m a r k e r sd e c r e a s e dw h i l en e u r o n a la n dg l i a lm a r k e r si n c r e a s -
ed. These data indicate that cNPCs cultured in UM retain
multipotency and the capacity to diﬀerentiate.
The source of the improvement in growth of cBPCs seen
in UM thus appears to reside in the beneﬁcial eﬀects of the
media constituents rather than aberrations of cellular pro-
liferation. There is no question that Ultraculture is a much
richer base medium, containing approximately 6 fold greater
total protein than SM. While it is tempting to speculate that
certain serum proteins or peptides may be critical toStem Cells International 9
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Figure 7: Eﬀect of diﬀerentiation conditions on expression of
markersbyimmunocytochemistry.Toexaminethelineagepotential
of cNPCs, P26 (4 month) cultures were grown in UM or UM-FBS
for 5 days and immunolabeled with antibodies (red) against nestin,
vimentin, β3-tubulin, Ki-67, and GFAP. Cell nuclei were labeled
with DAPI (blue). Scale bars represent 50μm.
the growth of feline progenitors, further work is needed to
deﬁne which particular components are responsible for the
dramatic improvements seen in the current study.
In summary, we have shown that the use of a highly en-
riched, serum-free medium allows the long-term propaga-
tionoffelineneuralprogenitorcells,somethingthatstandard
serum-freeconditionsdoespoorly,ifatall.Theresultingcells
retain multipotency and the ability to diﬀerentiate, as well as
a normal karyotype. This does not rule out the possibility
that the cells may have taken a signiﬁcant, but less obvious,
step towards spontaneous immortalization, and that the
growth-promoting inﬂuence of UM might be causative. For-
tunately, the resulting ability to generate and bank large
numbers of cNPCs should greatly facilitate additional exam-
ination of these cells, including both safety concerns and the
potential for therapeutic beneﬁts following transplantation.
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